Part-Time
Posted on 9/10/2025
Contracted VA outpatient clinics provider
No salary listed
Oak Ridge, TN, USA
In Person
Valor Healthcare provides outpatient medical services under contract to the U.S. Department of Veterans Affairs, running more than 30 VA Community Based Outpatient Clinics nationwide and serving over 110,000 veterans each year. Its clinics offer primary care, diagnostics, laboratory services, telehealth, and behavioral health, designed to meet veterans' needs with emphasis on security, privacy, and dignity. Care is organized around the VA’s Patient Aligned Care Team (PACT) model, with clinics coordinating closely with local VA medical centers to deliver coordinated, personalized care. By focusing on VA contracts and a nationwide veteran-focused network, Valor differentiates itself from general private providers and aims to deliver accessible, high-quality veteran care.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Dallas, Texas
Founded
2004
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Paid Sick Leave
Hybrid Work Options
Valor Healthcare to spend $5 Million to occupy 33,665 square feet of space in Denton Texas. Valor Healthcare to spend $5 Million to occupy 33,665 square feet of space in Denton Texas.Denton, Texas — According to state and local development sources, Valor Healthcare plans to invest $5,000,000.00 to build out 33,665 square feet of new space in Denton. The company plans to occupy the new space at 2322 San Jacinto Boulevard in Denton, on or about August 1, 2024. According to the company website Valor Healthcare was established in 2004 and is the largest, most experienced contract provider of VA CBOCs in the country, currently operating 50+ clinics across the United States that treat over 150,000 Veterans a year. Valor provides a full range of healthcare services that are tailored to meet the specific needs of federal government agencies and partners, including the U.S. Department of Veterans Affairs
First cohort of REGALS (T Regulatory Cells for ALS) has been completed.Ongoing Phase 1/ 1b study evaluating safety and efficacy of CK0803 (Neurotrophic T regulatory cells).HOUSTON, Jan. 19, 2024 /PRNewswire/ -- Michael E. DeBakey VA Medical Center announces opening of a new clinical trial using CK0803- off-the-shelf, allogeneic T regulatory cells that have been modified to target neuroinflammation to treat the fatal neurodegenerative disease – Amyotrophic Lateral Sclerosis (ALS).ALS Clinical Coordinator Richel Aliboso, NP, Principal Investigator Dr. James Orengo and Study Coordinator Michelle Espiritu are thrilled to enroll Houston VA Veterans into this groundbreaking clinical trial."We are very excited to open this first-in-class, best-in-class, cell therapy aimed to resolve neuroinflammation which fuels the ALS disease process. We believe that this novel approach of calming the inflamed microglia in the brain and spinal cord holds the promise for halting this relentlessly progressing disease", said Dr. James Orengo, principal investigator at the Michael E
Valor Healthcare Inc is proud to say that Valor Healthcare has achieved this and is now proudly Certified™ by Great Place To Work®.
Movement Interactive, Inc. collaborates with Valor Healthcare as a subcontractor to address health concerns and enable longevity.
GlobalMed's partner, Valor Healthcare, has a long history of providing exceptional primary care, mental health, and wellness services to veterans across the United States and is well-positioned to provide RPM services in partnership with GlobalMed and other teaming partners.